Programme ERS Presidential Summit
7-8 June, Dublin, Ireland
Research gaps, patient needs and innovative solutions: a forward look on
lung health research
Onsite programme (as presented)
The European Respiratory Society is hosting its Annual Presidential Summit this year in Dublin, Ireland
on 7th and 8th June. This annual event started in 2010 and aims to address and discuss pressing issues
at the interface of science and policy. The title of this year’s Summit is “Research gaps, patient needs
& innovative solutions: a forward look on lung health research”. The objective of the Summit is to
identify priority research topics that should be addressed at European level.
The ERS 2013 Presidential Summit is in association with the Irish Presidency of the Council of the
European Union.
DAY 1 – FRIDAY 7 JUNE 2013
12:00–13:00
Registration & Lunch
13:00-13:15
Opening and welcome
Francesco Blasi, ERS President (Milan, Italy)
13:15–13:30
Key note address
Eucharia Meehan, Director Irish Research Council (Dublin, Ireland)
13:30–14:45
Policies for lung health and research: can they make a difference?
Chaired by Francesco Blasi (Milan, Italy)
WHO actions to promote lung health
Hans Kluge WHO Europe (Copenhagen, Denmark)
Strategic research priority setting for health in Horizon 2020
G. Kogan European Commission, Research & Innovation (Brussels,
Belgium)
Health Research collaboration in Europe: an innovative initiative
H. Laverty, Senior Scientific Project Manager, Innovative Medicines
Initiative (Brussels, Belgium)
Health priorities during the Lithuanian Presidency
A. Veryga, representative of the Ministry of Health of Lithuania
Discussion
13:30–13:45
13:45–14:00
14:00–14:15
14:15–14:30
14:30–14:45
14:45–15:45
15:30–15:45
Lung Health: understanding risk factors
Chaired by Peter Barnes (London, United Kingdom)
Tobacco & the global attack on lung health
William MacNee (Edinburgh, United Kingdom)
From home to the work place: the impact of air quality
Nino Künzli (Basel, Switzerland)
The rising epidemic of social inequalities in Europe
Isabella Annesi-Maesano (Paris, France)
Discussion
15:45–16:15
Coffee break
16:15–18:30
Gaps and needs: defining patient-focused research
Chaired by Laurent P. Nicod (Lausanne, Switzerland)
Meeting the challenge of AMR and respiratory infections
F. Blasi presenting the slides of Tobias Welte (Hanover, Germany)
Personalised medicine: a step forward to better care?
S. Holgate (Southampton, United Kingdom)
Comorbidities and the ageing lung
J. Vestbo (Odense, Denmark)
Mainstreaming research for rare diseases
J-P. Sculier (Brussels, Belgium)
14:45–15:00
15:00–15:15
15:15–15:30
16:15–16:25
16:25-16:35
16:35-16:45
16:45-16:55
Followed by a panel discussion to identify concrete areas/topics where collaboration at EUlevel is necessary.
Chaired by Francesco Blasi (Milan, Italy)
Panel participants: P.J. Barnes (London, United Kingdom), S. Holgate (Southampton,
United Kingdom), K.F. Rabe (Großhansdorf, Germany), T. Welte
(Hanover, Germany), J-P. Sculier (Brussels, Belgium), J. Vestbo
(Odense, Denmark), B. Flood (Wexford, Ireland)
DAY 2 – SATURDAY 8 JUNE 2013
08:00–09:30
08:00–08:15
08:15–08:30
08.30-08.45
08.45-09.00
09.00-09.15
09:15–09:30
09:30–10:15
Needs and perceptions: understanding the patient
Chaired by Edward McKone, Irish Thoracic Society (Dublin, Ireland)
Key role of patients in clinical trials - COPD
Raymond McCrory (Northern Ireland)
The challenge of adherence to treatment in chronic diseases
G. Canonica (Genoa, Italy)
Living with a rare disease: patient’s view
Emer Reilly LAM Europe (Dublin, Ireland)
Katie Murphy Cystic Fibrosis Association of Ireland (Ireland)
Monica Fletcher (Warwick, United Kingdom), ELF Patient
Ambassador Programme
Discussion
09:45-10:15
Towards a new perspective on industry partnerships?
Chaired by Klaus Rabe (Grosshandorf, Germany)
Pharma view on public private partnerships
Giuseppe Recchia, GSK (Verona, Italy)
Discussion
10:15–10:45
Coffee break
10:45-11:00
Instructions for break-out sessions
11:00–12:00
Session 1
Break-out sessions on top priorities for collaborative research
Risk factors and Research priorities
Leader: Peter J. Barnes (London, United Kingdom)
Research priorities for Infection and ageing
Leader: Klaus F. Rabe (Grosshandorf, Germany)
Research priorities in early life and systemic biology
Leader:
Stephen T. Holgate (London, United Kingdom)
09:30–09:45
Session 2
Session 3
Outcomes should define top priorities for international/European research that will deliver
innovations, meet patient needs, and address urgent research gaps: through the formulation of
potential research topics for Horizon 2020.
12:00–12:30
Preparation of leaders’ reports
12:30–13:00
Leaders report back to Plenary
Chaired by Francesco Blasi (Milan, Italy)
13:00
Closing remarks
Francesco Blasi (Milan, Italy)